Hoekman John 4
4 · IMPEL PHARMACEUTICALS INC · Filed Feb 16, 2023
Insider Transaction Report
Form 4
Hoekman John
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-14+42,500→ 42,500 totalExercise: $2.29Exp: 2033-02-13→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.